Nature Publishes New Research from Vir Biotechnology Demonstrating the Capacity of Enhanced Monoclonal Antibodies to Induce Protective Adaptive Immunity to Viral Infection Data demonstrate potential to enhance effector function of monoclonal antibodies and induce a protective T-cell or “vaccinal” response Therapeutic approach previously applied to treatment of oncologic...